Quince Therapeutics Inc (QNCX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -317.051 | -30.96 | -37.496 | -48.974 | -55.746 | -43.57 | -23.093 |
Return on Equity (%) | 120.661 | 47.163 | -89.268 | -53.416 | -61.85 | -47.14 | -33.806 |
Return on Invested Capital (%) | -517.207 | -32.137 | -46.275 | -71.841 | -82.026 | -51.831 | -25.101 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | -0.923 | 20.932 | 4.298 | 5.831 | 3.943 | 2.62 | 0.088 |
Earnings Per Share | -3.64 | -3.657 | -1.376 | -2.601 | -2.991 | -1.43 | -0.732 |
Cash Per Share | 2.185 | 7.29 | 1.906 | 2.262 | 2.318 | 1.234 | 0.484 |
Working Capital Per Share | 1.718 | 20.846 | 3.616 | 4.091 | 3.24 | 2.509 | 1.583 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -3.64 | -3.657 | -1.376 | -2.601 | -2.991 | -1.437 | -0.737 |
EBITDA Per Share | -3.64 | -3.657 | -1.376 | -2.601 | -2.991 | -1.437 | -0.737 |
Free Cash Flow Per Share | -3.631 | -3.609 | -1.381 | -2.611 | -2.996 | -1.432 | -0.736 |
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 3,36M | 3,41M | 26,87M | 29,54M | 30,07M | 36,14M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | 36,14M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 81,4M |
Ratio cours/bénéfice | -2,73 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 4,13 |
Ratio prix/valeur comptable | 1,01 |
Rendement de dividende | - |
Actions en circulation | 44M |
Volume moyen (1 semaine) | 195,2k |
Volume moyen (1 mois) | 288,11k |
Variation sur 52 semaines | 56,78% |
Plus haut sur 52 semaines | 2,45 |
Plus bas sur 52 semaines | 0,5116 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales